Allogene retains control of cancer therapy after arbitration ruling

Go back to Allogene retains control of cancer therapy after arbitration ruling
(NASDAQ: ALLO) Delayed: 1.25 --0 (-0%)
Previous Close $1.25    52 Week High $ 
Open $1.25    52 Week Low $ 
Day High $1.25    P/E N/A 
Day Low $1.25    EPS $ 
Volume 6,774       

(NASDAQ: CLLS) Delayed: 0.98 --0 (-0%)
Previous Close $0.98    52 Week High $37.55 
Open $0.98    52 Week Low $16.35 
Day High $0.98    P/E N/A 
Day Low $0.98    EPS $0.00 
Volume 106